BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

552 hedge funds and large institutions have $15.6B invested in BioMarin Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 102 funds opening new positions, 186 increasing their positions, 175 reducing their positions, and 46 closing their positions.

Holders
552
Holders Change
+45
Holders Change %
+8.88%
% of All Funds
8.53%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.12%
New
102
Increased
186
Reduced
175
Closed
46
Calls
$157M
Puts
$137M
Net Calls
+$19.8M
Net Calls Change
+$85.5M

Top Buyers

1
Viking Global Investors
1
Viking Global Investors
Connecticut
$254M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$165M
3
Citadel Advisors
3
Citadel Advisors
Florida
$120M
4
PA
4
Perceptive Advisors
New York
$104M
5
ACA
5
Avoro Capital Advisors
New York
$247M

Top Sellers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.12B
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$114M
3
BlackRock
3
BlackRock
New York
$1.23B
4
Goldman Sachs
4
Goldman Sachs
New York
$72M
5
DLPIC
5
Davide Leone & Partners Investment Company
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FWIA
26
Fort Washington Investment Advisors
Ohio
$101M 1,143,631 +551,729 +93%
Rockefeller Capital Management
27
Rockefeller Capital Management
New York
$101M 1,139,837 -12,022 -1%
UBS AM
28
UBS AM
Illinois
$100M 1,132,246 +45,170 +4%
First Trust Advisors
29
First Trust Advisors
Illinois
$99.4M 1,124,774 +41,888 +4%
Charles Schwab
30
Charles Schwab
California
$97.3M 1,100,939 +49,535 +5%
Legal & General Group
31
Legal & General Group
United Kingdom
$95.9M 1,084,954 -15,908 -1%
CCM
32
Camber Capital Management
Massachusetts
$89.7M 1,015,000 -135,000 -12%
Deutsche Bank
33
Deutsche Bank
Germany
$83.1M 941,095 +48,216 +5%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$81.4M 921,722 +146,110 +19%
N
35
Natixis
France
$78.2M 884,926 -407,019 -32%
O
36
OrbiMed
New York
$76.1M 860,880 +749,980 +676%
Point72 Asset Management
37
Point72 Asset Management
Connecticut
$72.6M 821,796 +30,007 +4%
Goldman Sachs
38
Goldman Sachs
New York
$72M 815,067 -671,512 -45%
Nuveen Asset Management
39
Nuveen Asset Management
Illinois
$70.5M 797,732 -15,422 -2%
Victory Capital Management
40
Victory Capital Management
Texas
$65.1M 736,471 +83 +0%
Millennium Management
41
Millennium Management
New York
$62.6M 708,036 -140,452 -17%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$62.1M 702,888 -2,022 -0.3%
Swiss National Bank
43
Swiss National Bank
Switzerland
$61.6M 696,898 -25,700 -4%
Renaissance Technologies
44
Renaissance Technologies
New York
$57.5M 651,060 +269,589 +71%
Marshall Wace
45
Marshall Wace
United Kingdom
$55.6M 629,434 +293,449 +87%
EAM
46
Erste Asset Management
Austria
$54.2M 608,300 – –
Sumitomo Mitsui Trust Group
47
Sumitomo Mitsui Trust Group
Japan
$49.8M 563,683 +34,324 +6%
Jennison Associates
48
Jennison Associates
New York
$48.8M 552,544 +552,544 New
Dimensional Fund Advisors
49
Dimensional Fund Advisors
Texas
$48.8M 552,022 +26,813 +5%
SI
50
Scout Investments
Missouri
$47.3M 535,749 +115,432 +27%
1
2
3 4 5